US › Healthcare

Quantum BioPharma Ltd. (QNTM)

US · Healthcare · Biotechnology

$2.47-8.86%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-3.2M

EPS

$-0.47

EPS estimate

$-0.59

EPS came in at -0.47 against a street estimate of -0.59 — a beat of 20.3%.

Key statistics

Market cap

$18.9M

Forward P/E

0.0

P/B

3.91

Book value

$1.05

EPS (TTM)

$-4.98

52-week high

$16.36

52-week low

$2.07

50-day MA

$3.37

200-day MA

$4.30

Beta

0.38

Analyst view

Analysts rate Quantum BioPharma Ltd. a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $12.24.

Shareholding

Insiders

8.40%

Institutions

12.00%

Largest institutional holders

Fund	Stake
AdvisorShares Investments, LLC	2.52%
Jane Street Group LLC	0.60%
Platform Technology Partners	0.51%
UBS Group AG	0.41%
Steward Partners Investment Advisory, LLC	0.34%
Citadel Advisors Llc	0.20%
Marex Group Ltd	0.17%
Mariner Wealth Advisors LLC	0.12%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Quantum BioPharma Ltd. — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.